ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1482	National Cancer Institute	Html	en	Thyroid Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of thyroid cancer.	NX Regional lymph 0.514232 differentiated thyroid carcinoma 0.483242 thyroid capsule 0.458348 lymph node recurrence 0.424478 lymph node involvement. 0.433258 thyroid carcinoma 0.494127 follicular thyroid carcinoma 0.43746 minimal extrathyroid extension 0.497486 papillary thyroid cancer 0.500545 recurrent differentiated thyroid 0.423584 perithyroid soft tissues 0.49864 M0 T2 Tumor 0.418332 N1a Metastases 0.452974 patients 0.4225 lymph node biopsy 0.465877 sentinel lymph node 0.465511 thyroid cancer. 0.408942 encases carotid artery 0.459248 lymph nodes 0.70121 papillary thyroid microcarcinomas 0.421769 papillary thyroid carcinoma 0.467474 prelaryngeal/Delphian lymph nodes 0.599278 T1b Tumor 0.476542 thyroid diseases 0.408003	T1a Tumor 0.476741 thyroid gland 0.406975 thyroid cancer 0.570421 mediastinal lymph nodes 0.577558 thyroid autoantibodies 0.408316 greatest dimension 0.710356 follicular thyroid cancer 0.472046 subcutaneous soft tissues 0.453725 soft tissues 0.502801 recurrent laryngeal nerve 0.458581 superior mediastinal lymph 0.567495 tumor suppressor gene 0.41425 regional lymph node 0.969698 distant metastasis 0.429776 TX Primary tumor 0.476275 cm 0.593737 primary tumor 0.496822 lymph node status 0.43297 differentiated thyroid cancer 0.496492 lymph node involvement 0.43209 M0 T1 Tumor 0.448756 tumor 0.667722 regional lymph nodes 0.569893 lymph node metastases 0.446319	CLICK HERE
1489	National Cancer Institute	Html	en	Salivary Gland Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of salivary gland cancer.	salivary gland carcinoma 0.511905 salivary duct carcinoma 0.495372 salivary neoplasms 0.436633 salivary gland neoplasms 0.699057 salivary gland tumors 0.679256 Oral Surg Oral 0.463588 Oral Med Oral 0.447637 Med Oral Pathol 0.44551 Labial salivary gland 0.469995 malignant salivary gland 0.526645 salivary gland neoplasm 0.484554 acinic cell carcinoma 0.43649 Salivary Gland Disease 0.467146 minor salivary glands 0.598035 epithelial salivary gland 0.497367 minor salivary glands. 0.45198 Gnepp DR 0.473942 Auclair PL 0.442506 salivary gland tissue 0.459874 Ellis GL 0.451621 salivary gland 0.899362 mesenchymal salivary gland 0.475624 mucoepidermoid carcinoma 0.443769 intraoral minor salivary 0.423491	Salivary gland tumours 0.500385 salivary gland lesion 0.478189 intraoral salivary glands 0.465746 parotid gland 0.430561 adenoid cystic carcinoma 0.455777 PUBMED Abstract 0.424085 major salivary glands 0.755909 salivary gland neoplasms. 0.489141 salivary gland register 0.455761 minor salivary gland 0.596497 common salivary gland 0.491012 Central salivary gland 0.46762 salivary gland accessions 0.477176 cell carcinoma 0.493942 salivary gland regions 0.454552 salivary gland sites 0.489141 Abstract 0.471491 salivary glands. 0.452306 salivary glands 0.905936 Surg Oral Med 0.463412 salivary gland tumor 0.497715 major salivary gland 0.545945 major salivary glands. 0.437313 salivary gland origin 0.593941	CLICK HERE
1556	National Cancer Institute	Html	en	Colorectal Cancer Prevention (PDQ®)–Patient Version	Expert-reviewed information summary about factors that may influence the risk of developing of colorectal cancer and about research aimed at the prevention of this disease.	cancer treatment 0.462885 cancer prevention trials 0.5302 colorectal cancer prevention 0.614686 colorectal polyps 0.56189 protective factors 0.497455 following PDQ summaries 0.48755 PDQ cancer information 0.608246 new colorectal cancers 0.563344 clinical trials 0.59581 possible harms 0.498355 increased risk 0.474738 cancer information summary 0.540977 risk factors 0.560326 breast cancer prevention 0.482223 colorectal cancer 0.972144 new colorectal cancer 0.620653 lower risk 0.461958 cancer patients 0.460978 nonpolyposis colon cancer 0.4955 cancer risk factor 0.521529 colon cancer prevention 0.494063 NCI’s PDQ 0.461756 Clinical Trials section 0.458686 smaller polyps lowers 0.458496	NCI PDQ cancer 0.516757 rectal cancer prevention 0.488321 large colorectal adenomas 0.566232 hormone replacement therapy 0.492755 familial adenomatous polyposis 0.499723 cancer risk factors 0.517883 colorectal adenomas 0.616144 cancer protective factor 0.49566 Cancer Information Service 0.487513 prevention clinical trials 0.487754 Prevention Editorial Board 0.488084 treatment clinical trials 0.458488 National Cancer Institute 0.559763 cancer doctors 0.458093 colorectal cancer cases 0.619218 colon cancer 0.508406 Cancer Care page 0.480229 PDQ database 0.45787 PDQ summary 0.478855 invasive colorectal cancer 0.6296 cancer clinical trials 0.495703 cancer information summaries 0.492581 comprehensive cancer information 0.492387 risk 0.615513	CLICK HERE
1582	National Cancer Institute	Html	en	Adult Soft Tissue Sarcoma Treatment (PDQ®)–Patient Version	Soft tissue sarcomas can form almost anywhere in the body, but are most common in the head, neck, arms, legs, truck, and abdomen. Find out about risk and genetic factors, symptoms, tests to diagnose, prognosis, staging, and treatment for soft tissue sarcoma.	cancer treatment 0.262443 malignant tumor cells 0.254786 cancer spreads 0.245112 body 0.294182 type 0.25634 PDQ cancer information 0.274383 clinical trial search 0.274958 clinical trials 0.461076 nearby lymph nodes 0.239706 cancer information summary 0.260539 clinical trial 0.328582 patients 0.25186 blood vessels 0.240907 treatment clinical trial 0.238552 subcutaneous tissue 0.292398 NCI PDQ cancer 0.240642 Treatment Option Overview 0.242732 lymph nodes 0.261315 radiation therapy 0.391981 little normal tissue 0.262689 soft tissue sarcoma 0.92025 General information 0.241563 treatment 0.357792 wide local excision 0.284219 nearby healthy tissue 0.249677	NCI-supported cancer 0.247977 cancer cells 0.331726 laboratory test 0.23958 soft tissues 0.24063 connective tissue 0.264853 treatment clinical trials 0.254055 National Cancer Institute 0.283258 soft tissue sarcomas 0.301359 new treatment 0.260355 adult soft tissue 0.678017 tissue sarcoma cells 0.278793 external radiation therapy 0.248848 primary tumor 0.244329 metastatic tumor 0.239026 tissue samples 0.246374 Regional hyperthermia therapy 0.239395 cancer clinical trials 0.280749 stage 0.259627 tumor 0.3265 Tissue Sarcoma Treatment 0.274121 treatment options 0.240625 internal radiation therapy 0.238752 cancer 0.489567 information 0.283228	CLICK HERE
1612	National Cancer Institute	Html	en	Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of renal pelvis and ureter transitional cell cancer.	general cancer information 0.245004 treatment 0.36943 cancer treatment 0.274834 new cancer treatments 0.244453 NCI-supported cancer 0.252295 cancer cells 0.305937 cancer spreads 0.254859 body 0.283889 diagnose transitional cell 0.268084 Cancer Information Service 0.245843 PDQ cancer information 0.2892 Recurrent transitional cell 0.259741 segmental resection 0.252407 kidney 0.248946 clinical trial search 0.276195 treatment clinical trials 0.260027 National Cancer Institute 0.300743 clinical trials 0.500017 Ureter Treatment 0.280286 metastatic transitional cell 0.241447 PDQ Transitional Cell 0.249302 cancer information summary 0.272322 clinical trial 0.418117 new treatment 0.269914	breast cancer prevention 0.240544 renal cell cancer 0.301024 ureter 0.545878 patients 0.265691 Blood. The cancer 0.243945 Cell Cancer Treatment 0.266901 PDQ summary 0.241392 treatment clinical trial 0.245285 kidney cancer 0.240494 NCI PDQ cancer 0.250983 cancer research process 0.24139 cancer clinical trials 0.286739 tests 0.24917 stage 0.247801 certain pain medicines 0.268283 tumor 0.244567 treatment options 0.255801 cancer information summaries 0.244613 Treatment Editorial Board 0.244593 comprehensive cancer information 0.244987 renal pelvis 0.969529 standard treatment 0.251972 General information 0.241791	CLICK HERE
1775	National Cancer Institute	Html	es	Náuseas y vómitos relacionados con el tratamiento (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las náuseas y los vómitos como complicaciones a causa del cáncer o su tratamiento. Se describen abordajes de tratamiento de las náuseas y los vómitos.	chemotherapy induced nausea 0.342573 conditioned nausea 0.336948 Bouganim N 0.33134 delayed chemotherapy-induced nausea 0.334556 anticipatory nausea 0.772561 schwartzberg ls 0.356266 horas vo 0.591535 Krozely MG 0.34156 Hesketh PJ 0.353455 colorectal cancer 0.336446 chemotherapy-induced nausea 0.951327 dosis vo 0.347133 continuación presente nva 0.332752 mg vr 0.340801 community clinical practices 0.338332 anticipatory emesis 0.337674 cancer chemotherapy 0.773091 Pain Symptom Manage 0.361458 Support Oncol 0.346357 quimioterapia categoría 0.357422 Roscoe JA 0.415752 NyV agudos 0.347107 mg im 0.432997 NVIQ agudos 0.337444 controlling chemotherapy-induced nausea 0.364663	delayed nausea 0.337245 Care Cancer 0.464148 Bovbjerg DH 0.349781 VO Inhibidor 0.357448 mg vo 0.767769 quimioterapia vo 0.485969 Kris MG 0.406292 quimioterapia vo la 0.389831 significant clinical problem 0.339573 Prospective validation 0.334589 Consult Clin Psychol 0.417355 clinical oncology 0.347599 quimioterapia iv 0.373245 Hickok JT 0.353347 días vo inhibidor 0.344362 chemotherapy patients 0.331687 Clin Oncol 0.384683 sistema nervioso central 0.357893 patients treated 0.340656 días vo 0.360421 Morrow GR 0.513036 potencial emetógeno 0.502334 Clinical roundtable monograph 0.340704 Adv Hematol Oncol 0.339165	CLICK HERE
1822	National Cancer Institute	Html	es	Tratamiento del linfoma no Hodgkin infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del linfoma no Hodgkin infantil.	LNH sobrevivirán 0.259398 Zimmermann M 0.292078 Pediatric Non-Hodgkin Lymphoma 0.307431 with b-cell 0.245734 células t 0.360685 large cell lymphoma 0.592792 large b-cell lymphoma 0.310638 Burkitt lymphoma 0.390944 anaplastic large-cell lymphoma 0.391142 B-cell lymphoma treated 0.259053 Gerrard M 0.253938 Burkitt's lymphoma 0.311811 Non-Hodgkin Lymphoma Staging 0.255329 linfoma folicular tipo 0.251963 childhood t-cell lymphoblastic 0.240771 Leuk Lymphoma 0.317156 Perkins SL 0.288471 childhood cancer 0.239116 or relapsed lymphoma 0.247628 malignant lymphoma 0.246238 Sposto R 0.298634 Non-Hodgkin Lymphoma Response 0.260692 patients with lymphoma 0.260427 group study 0.273614 estadio iv 0.240422	Cairo MS 0.242979 Pediatr Blood Cancer 0.510662 tipo burkitt células 0.244366 Cancer Group Study 0.240733 lymphoblastic lymphoma 0.400773 Clin Oncol 0.804352 B-cell non-Hodgkin 0.317262 sistema nervioso central 0.275043 childhood b-cell 0.244175 lymphoma kinase-positive 0.244682 non-hodgkin lymphoma 0.692526 Children's Cancer Group 0.319924 lymphoma clinical trials 0.248853 b-cell lymphoma 0.27822 tipo burkitt 0.265416 non-hodgkin's lymphoma 0.96423 mediastinal b-cell lymphoma 0.256031 group report 0.255665 children's oncology group 0.421119 anaplastic large cell 0.389279 Burkitt's lymphoma from 0.271141 lymphoma with tumor 0.259565 células b 0.2577 Burkhardt B 0.329473	CLICK HERE
1925	National Cancer Institute	Html	es	Tratamiento del cáncer de hipofaringe (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de hipofaringe.	Neck Cancer 0.247768 siguientes procedimientos 0.753135 siguientes aspectos 0.304732 rayos x 0.282557 pequeñas marcas 0.25053 estadio ivc 0.310167 enlace drugs approved 0.28833 estadio iva 0.312892 vías respiratorias 0.282072 National Cancer Institute 0.233317 siguientes opciones 0.237415 siguientes riesgos 0.225706	realidad células 0.310814 cuerpo.ampliar radioterapia 0.360468 Instituto Nacional 0.267315 hormonas tiroideas 0.252232 malla ayuda 0.248727 PDQ Tratamiento 0.272276 paciente fuma 0.301748 Physician Data Query 0.341971 estadio i 0.315197 ganglio linfático mide 0.903903 glándula tiroidea 0.554743 siguientes estadios 0.417752	CLICK HERE
2964	National Cancer Institute	Html	en	E-Cigarettes	If you’re thinking about using an e-cig, here are three things you should know.	hookah water pipe 0.494728 large premium cigars 0.459683 oral tobacco 0.537822 greater risks 0.403027 cancer-causing substances 0.387897 chemical additives 0.392918 burning cigarette 0.414008 throat cancer 0.383899 lung cancer 0.382731 tobacco 0.978071 supportive friends 0.453267 cancer-causing chemicals 0.389232 hookah smoke 0.446625 Cigar smoke 0.40643 greater health issues 0.438887 carbon monoxide 0.384792 cigar tobacco 0.526627 paper wrapping 0.393371 leaf tobacco 0.522574 tobacco products 0.765605 harm brain development 0.443591 high risk 0.381422 little filtered cigars 0.462027 older siblings 0.385847 Hookah tobacco 0.577414	healthy way 0.432788 Nicotine exposure 0.405523 toxic chemicals 0.388306 harmless water vapor 0.448644 potentially harmful chemicals 0.482948 high levels 0.460808 health consequences 0.391113 cigarette smoke 0.424559 cigarette smoking 0.578732 heart disease 0.388527 DipfreeTXT program 0.386418 vape pens 0.380351 hookah smoking 0.490187 multiple tobacco products 0.584428 spitting tobacco 0.542435 mouth cancer 0.379991 size—from smaller cigars 0.460695 cigarette tobacco 0.544703 Cigar users 0.389386 quitSTART app 0.388192 e-cigarettes 0.388072 smokeless tobacco 0.780551 risks 0.529273 health risks 0.470569	CLICK HERE
15634	National Cancer Institute	Html	en	Step 3: Peer Review and Funding Outcomes	The NCI review process seeks to achieve a balanced grant portfolio, that addresses scientific priorities. Learn about NCI’s peer review for grant applications.	Final funding decisions 0.68801 conservative funding range 0.692235 Funding Opportunity Announcement 0.669325 grant applications 0.543909 grant review cycle 0.655483 previously reviewed submissions 0.591298 scientific research community 0.67817 grants management specialist 0.65539 JIT requirements 0.569359 NCI budget 0.675257 specific grant application 0.663769 funding guidelines 0.594989 Grants Policy Manual 0.654435 grants management 0.718868 Resubmission Applications 0.561239 additional information 0.630031 funding mechanisms 0.587684 future funding 0.591477 preliminary funding allocations 0.74522 JIT Procedures 0.570833 program allocations 0.582504 program priorities 0.540659 NCI division 0.672087 grants management staff 0.632016 JIT information 0.763408	review percentile/impact score 0.647883 NIH Policy 0.59572 responsible NIH official 0.747181 Peer Review process 0.887529 NCI Scientific Program 0.984221 NCI Peer Review 0.873194 important scientific priorities 0.646164 nih peer review 0.942228 Program Leadership Committee 0.639488 subsequent new application 0.637696 unsuccessful initial submission 0.60519 scientific program staff 0.658004 Scientific Review 0.61867 promising scientific opportunities 0.644998 administrative review 0.543867 following JIT information 0.687226 NCI grants process 0.840796 unsuccessful initial application 0.638737 scientific merit 0.540216 Scientific Program Leadership 0.821474 funding decisions 0.80612 dual review process 0.70096 timely review 0.580483 Public Health Service 0.644114	CLICK HERE